Enhancing the rational use of new medicines across European health care systems

European Journal of Clinical Pharmacology

Volumn 64, Issue 12, 2008, Pages 1137-1138

  Garattini, Silvio ^a   Bertele', Vittorio ^a   Godman, Brian ^a   Haycox, Alan ^b   Wettermark, Björn ^c,d   Gustafsson, Lars L ^c  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b UNIVERSITY OF LIVERPOOL MANAGEMENT SCHOOL   (United Kingdom)

^c KAROLINSKA INSTITUTE   (Sweden)

^d STOCKHOLM COUNTY COUNCIL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

NEW DRUG;

DRUG USE; EDITORIAL; EUROPE; HEALTH CARE SYSTEM; HEALTH PROGRAM; HEALTH SERVICE; PRIORITY JOURNAL; RESOURCE ALLOCATION;

DELIVERY OF HEALTH CARE; DRUG UTILIZATION REVIEW; EUROPE;

EID: 57049114953     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-008-0537-z     Document Type: Editorial

References (6)

1. L Garattini N Motterlini D Cornago 2008 Prices and distribution margins of in-patent drugs in pharmacy: A comparison in seven European countries Health Policy 85 305 813
2. TH Lee EJ Emanuel D Cornago 2008 Tier 4 drugs and fraying of the social compact. New Engl J Medicine 359 333 335
3. A Jack 2008 Balancing big pharma's books BMJ 336 418 419
4. H Melander J Ahlqvist-Rastad G Meijer B Beermann 2003 Evidence b(i)ased medicine - selective reporting from studies sponsored by pharmaceutical industry: review of studies in new drug applications BMJ 326 1171 1173
5. A-W Chan A Hróbjartsson M Haaber P Gøtzsche D Altman 2004 Empirical evidence for selective reporting of outcomes in randomised trials JAMA 291 2457 2465
6. S Garattini V Bertele' 2007 How can we regulate medicines better BMJ 335 803 805